The most common indication for Butorphanol Tartrate is management of migraine using the intranasal spray formulation. It is a morphinan-type synthetic agonist–antagonist opioid analgesic developed by Bristol-Myers.. Reference standards of Butorphanol Tartrate API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
Butorphanol Tartrate
Catalogue No.:PA 02 88000
CAS :
Molecular Formula : C25H35NO8
Molecular Weight : 477.55
3,14-Dihydroxymorphinan
Catalogue No.:PA 02 0881000
Molecular Formula : C16H21NO2
Molecular Weight : 259.35
(-)-3-Methoxybutorphanol
Catalogue No.:PA 02 0881001
Molecular Formula : C22H31NO2
Molecular Weight : 341.5
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
